Scott Woods, MD
Professor of Psychiatry
Research & Publications
Biography
News
Research Summary
Dr. Woods conducts studies aiming to improve prediction of which prodromal adolescents and young adults will progress to frank psychosis and which will remit. He also conducts studies aiming to improve the treatment of current symptoms and to prevent progression.
Specialized Terms: Risk syndrome for psychosis; Psychosis prodrome; Attenuated psychosis disorder
Extensive Research Description
Predictors and Mechanisms of Conversion to Psychosis (MH082022)
Aspirin vs placebo for the psychosis prodrome
D-serine for the psychosis prodrome (MH074356)
Dutetrabenzine for tardive dyskinesia
Huperzine for cognitive enhancement in schizophrenia (MH083436)
Coauthors
Research Interests
Adolescent Psychiatry; Psychiatry; Psychotic Disorders; Prodromal Symptoms
Selected Publications
- Current status specifiers for patients at clinical high risk for psychosisWoods SW, Walsh BC, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen R, Perkins DO, Seidman LJ, Tarbox SI, Tsuang MT, Walker EF, McGlashan TH. Current status specifiers for patients at clinical high risk for psychosis. Schizophrenia Research 2014, 158: 69-75. PMID: 25012147, PMCID: PMC4152558, DOI: 10.1016/j.schres.2014.06.022.
- Psychotropic medication use in youth at high risk for psychosis: Comparison of baseline data from two research cohorts 1998–2005 and 2008–2011Woods SW, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, McGlashan TH. Psychotropic medication use in youth at high risk for psychosis: Comparison of baseline data from two research cohorts 1998–2005 and 2008–2011. Schizophrenia Research 2013, 148: 99-104. PMID: 23787224, PMCID: PMC3867209, DOI: 10.1016/j.schres.2013.05.019.
- Glycine treatment of the risk syndrome for psychosis: Report of two pilot studiesWoods SW, Walsh BC, Hawkins KA, Miller TJ, Saksa JR, D'Souza DC, Pearlson GD, Javitt DC, McGlashan TH, Krystal JH. Glycine treatment of the risk syndrome for psychosis: Report of two pilot studies. European Neuropsychopharmacology 2012, 23: 931-940. PMID: 23089076, PMCID: PMC4028140, DOI: 10.1016/j.euroneuro.2012.09.008.
Clinical Trials
| Conditions | Study Title |
|---|---|
| Mental Health & Behavioral Research | Study of Brain Function Across the Lifespan |
| Mental Health & Behavioral Research | Sleep Dependent Learning in Schizophrenia and Psychosis Risk Syndrome |
| Mental Health & Behavioral Research | ProNET |